DK402485A - TUMOR THERAPEUTIC AND PROCEDURE FOR ITS PREPARATION - Google Patents

TUMOR THERAPEUTIC AND PROCEDURE FOR ITS PREPARATION Download PDF

Info

Publication number
DK402485A
DK402485A DK402485A DK402485A DK402485A DK 402485 A DK402485 A DK 402485A DK 402485 A DK402485 A DK 402485A DK 402485 A DK402485 A DK 402485A DK 402485 A DK402485 A DK 402485A
Authority
DK
Denmark
Prior art keywords
procedure
preparation
tumor therapeutic
monoclonal antibodies
antigens
Prior art date
Application number
DK402485A
Other languages
Danish (da)
Other versions
DK172253B1 (en
DK402485D0 (en
Inventor
Klaus Bosslet
Hans-Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK402485D0 publication Critical patent/DK402485D0/en
Publication of DK402485A publication Critical patent/DK402485A/en
Application granted granted Critical
Publication of DK172253B1 publication Critical patent/DK172253B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Abstract

The process entails either tumour cells which carry antigens which are bound by the monoclonal antibodies described in German Offenlegungsschrift 33 29 184 being dried or stabilised by a chemical treatment, or antigens being isolated from human cells using these monoclonal antibodies, and converted into a therapeutic agent, adding neuraminidase where appropriate.
DK402485A 1984-09-06 1985-09-03 Tumor Therapeutics, Method for its Preparation, and Use of Human Tumor Cells to Prepare a Therapeutic for the Treatment of Tumor Disorders DK172253B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843432714 DE3432714A1 (en) 1984-09-06 1984-09-06 TUMOR THERAPEUTICS AND METHOD FOR THE PRODUCTION THEREOF
DE3432714 1984-09-06

Publications (3)

Publication Number Publication Date
DK402485D0 DK402485D0 (en) 1985-09-03
DK402485A true DK402485A (en) 1986-03-07
DK172253B1 DK172253B1 (en) 1998-02-09

Family

ID=6244749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK402485A DK172253B1 (en) 1984-09-06 1985-09-03 Tumor Therapeutics, Method for its Preparation, and Use of Human Tumor Cells to Prepare a Therapeutic for the Treatment of Tumor Disorders

Country Status (13)

Country Link
EP (1) EP0173951B1 (en)
JP (1) JPS6168427A (en)
AT (1) ATE64531T1 (en)
CA (1) CA1277600C (en)
DE (2) DE3432714A1 (en)
DK (1) DK172253B1 (en)
ES (1) ES8704082A1 (en)
FI (1) FI88360C (en)
GR (1) GR852149B (en)
IE (1) IE58638B1 (en)
IL (1) IL76289A (en)
PT (1) PT81093B (en)
ZA (1) ZA856807B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3806565A1 (en) * 1988-03-01 1989-09-14 Deutsches Krebsforsch VIRUS-MODIFIED TUMOR VACCINES FOR THE IMMUNOTHERAPY OF TUMOR METAL KEYS
AT398900B (en) * 1991-02-12 1995-02-27 Pekar Rudolf Dr Vaccine for immunotherapy
US7070782B1 (en) 1992-11-05 2006-07-04 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
US6953668B1 (en) 1992-11-05 2005-10-11 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen
EP1757694A3 (en) * 1992-11-05 2008-02-27 Sloan Kettering Institute For Cancer Research Prostate-specific membrane antigen
US7105159B1 (en) 1992-11-05 2006-09-12 Sloan-Kettering Institute For Cancer Research Antibodies to prostate-specific membrane antigen
US6569432B1 (en) 1995-02-24 2003-05-27 Sloan-Kettering Institute For Cancer Research Prostate-specific membrane antigen and uses thereof
DE19506483A1 (en) * 1995-02-24 1996-08-29 Jens Dr Dr Atzpodien Antitumour vaccines
DE69635801T2 (en) 1995-02-24 2006-11-02 Sloan-Kettering Institute For Cancer Research PROSTATE-SPECIFIC MEMBRANES ANTIGEN AND ITS APPLICATIONS
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
AU2002356844C1 (en) 2001-10-23 2010-03-04 Amgen Fremont Inc. PSMA antibodies and protein multimers
CN1315536C (en) * 2002-09-13 2007-05-16 李进 Novel vaccine of tumor antigen, its preparation method and vaccine composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
DE2643215A1 (en) * 1976-09-25 1978-04-06 Bayer Ag CANCEROSTATICALLY EFFECTIVE PREPARATIONS FROM TUMOR CELLS AND A METHOD FOR THEIR PRODUCTION
ZA776822B (en) * 1976-11-24 1979-06-27 D Mccollester Vaccine and method for immunotherapy of neoplastic disease
DE2918927A1 (en) * 1979-05-10 1980-11-20 Hans Prof Dr Limburg MEDICINAL PRODUCT FOR TREATING CARCINOMAS AND METHOD FOR THE PRODUCTION THEREOF
US4446122A (en) * 1979-12-28 1984-05-01 Research Corporation Purified human prostate antigen
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
DE3329184A1 (en) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR MEMBRANE-ASSOCIATED ANTIGENS
DE3416774A1 (en) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg MONOCLONAL ANTIBODIES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

Also Published As

Publication number Publication date
ATE64531T1 (en) 1991-07-15
ES546701A0 (en) 1987-03-16
EP0173951A2 (en) 1986-03-12
FI853389L (en) 1986-03-07
DE3432714A1 (en) 1986-04-24
EP0173951A3 (en) 1988-06-08
IL76289A0 (en) 1986-01-31
DK172253B1 (en) 1998-02-09
JPS6168427A (en) 1986-04-08
DE3583265D1 (en) 1991-07-25
FI88360B (en) 1993-01-29
ES8704082A1 (en) 1987-03-16
CA1277600C (en) 1990-12-11
IL76289A (en) 1992-01-15
GR852149B (en) 1986-01-03
EP0173951B1 (en) 1991-06-19
IE852191L (en) 1986-03-06
PT81093A (en) 1985-10-01
FI853389A0 (en) 1985-09-04
PT81093B (en) 1988-07-01
DK402485D0 (en) 1985-09-03
ZA856807B (en) 1986-04-30
IE58638B1 (en) 1993-10-20
FI88360C (en) 1993-05-10

Similar Documents

Publication Publication Date Title
IL153996A0 (en) Polypeptides containing at least a portion of an ovarian carcinoma protein, polynucleotides encoding the same and pharmaceutical compositions containing the same
EP0161606A3 (en) Drug, and methods of preparing and using it for treatment of tumors
NO884795D0 (en) RECOMBINANT, HUMAN IMMUNOGLOBULIN AND PROCEDURE FOR PREPARING THIS.
DK101890A (en) MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-4 AND HYBRIDOMAES PRODUCING SUCH
DK69890A (en) MONOCLONAL ANTIBODIES REACTIVE WITH CACHETIN
NO904368L (en) CROSS-BONDED ANTIBODIES AND PROCEDURES FOR THEIR PREPARATION.
NO871025L (en) POLYPEPTID, DNA AND PROCEDURE FOR PREPARING THEREOF.
DK402485A (en) TUMOR THERAPEUTIC AND PROCEDURE FOR ITS PREPARATION
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
GR3005768T3 (en)
DE3173342D1 (en) Agent for tumor localization and therapy with labeled antibodies and antibody fragments
NO965395D0 (en) Human monoclonal antibodies specific for cell cycle-independent glioma surface antigen
DK78183D0 (en) ANTIBODIES AND ANTIGENS USED FOR CANCER DIAGNOSIS AND TREATMENT
EP0194851A3 (en) Human tumor therapy
DK169987D0 (en) HUMAN TUMOR-ASSOCIATED ANTIGEN, CA-OU1
EP0268640A4 (en) Vaccine for stimulating or enhancing production of antibodies directed against gm2.
DK107787A (en) METHOD AND PREPARATION FOR TREATMENT OF CANCER AND NON-TEMPORARY TUMORS
EP0328578A4 (en) Antigen recognized by mca 16-88.
EP0166458A3 (en) Monoclonal antibody capable of specifically distinguishing human hepato-carcinoma cells
NO822801L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2.5 DISUBSTITUTED FURANTS
DK420183D0 (en) ALFA, BETA-UNSATURED PREPARATION POLYMES AND PROCEDURES FOR PRODUCING THEREOF
ATE95426T1 (en) HUMAN CARCINOMA-ASSOCIATED ANTIGEN AND ANTIBODIES BINDING TO THIS ANTIGEN.
IT8220082A0 (en) COMPOSITION SUITABLE FOR THE THERAPEUTIC TREATMENT OF TUMORS.
ATE17190T1 (en) AGENT FOR TUMORS LOCALIZATION AND THERAPY WITH LABELED ANTIBODIES AND ANTIBODY FRAGMENTS.
DK354288A (en) CHEMICAL ANTIBODY WITH SPECIFICITY OVER HUMANT TUMOR ANTIGEN

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed